Differential proteolytic activity and induction of apoptosis in fibrous versus atheromatous plaques in carotid atherosclerotic disease

Purpose: Atherosclerotic plaque instability may be a contributing factor to plaque complications, such as rupture, thrombosis, and embolization. Of th e two types of plaques, atheromatous and fibrous, the atheromatous type has been reported to be vulnerable and unstable. This instability may be relat ed to changes in the cell cycle and extracellular matrix degradation. Apopt osis may weaken the plaque structurally. In addition, alteration of the cel lular component may lead to imbalances in associated proteolytic activity. Our study was designed to compare the two types of plaques in terms of apop tosis, apoptosis-inducing factors, namely Fas/CD95/APO-1 and CPP-32/YAMA/ca spase-3, and proteolytic activity. Methods: Carotid artery plaques were obtained from patients undergoing enda rterectomy and were classified as either atheromatous or fibrous on the bas is of established criteria. Histologic study included hematoxylin and eosin staining, Verhoeff's van Gieson elastin staining, and trichrome staining. Detection of apoptosis was performed with the TUNEL assay. Immunohistochemi cal studies were performed to localize the expression of CPP-32/YAMA and Fa s/CD95. Gelatin gel zymography was used to compare proteolytic activity lev els in the two types of plaque. Results: Apoptosis was significantly higher (P < .001) in atheromatous plaq ues (4.90% +/- 1.27% [SEM]) as compared with fibrous plaques (0.86% +/- 0.4 6% [SEM]). Zymography demonstrated elevated levels of proteinases in athero matous plaques. Immunohistochemistry revealed significant increases in the expression of Fas/CD95 (P < .04) and CPP-32/YAMA (P < .001) in atheromatous : plaques as compared with that in fibrous plaques. Conclusions: This is the first study comparing molecular factors that rende r atheromatous plaques more susceptible to rupture than fibrous plaques. Th e higher number of apoptotic cells seen in atheromatous plaques as compared with fibrous plaques could contribute to their greater instability. Immuno reactivity to cytoplasmic death domain, Fas/CD95 and CPP-32/YAMA, a promine nt mediator of apoptosis, was consistent with the numbers of apoptotic cell s detected. The increased levels of proteolytic activity in atheromatous pl aques may make these plaques more prone to rupture. These data identifying some of the molecular events and biochemical pathways associated with plaqu e vulnerability may help in the development of new strategies to prevent pl aque rupture.